What is the appropriate dosing of piperacillin‑tazobactam (Zosyn) for a child weighing 35 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Zosyn Dosing for 35 kg Child

For a child weighing 35 kg, the appropriate dose of piperacillin-tazobactam (Zosyn) is 112.5 mg/kg (100 mg piperacillin/12.5 mg tazobactam component) every 8 hours for appendicitis/peritonitis, or every 6 hours for nosocomial pneumonia, administered as a 30-minute intravenous infusion.

FDA-Approved Dosing

The FDA label provides clear weight-based dosing for pediatric patients 1:

For children >9 months of age (which includes a 35 kg child):

  • Appendicitis/Peritonitis: 112.5 mg/kg every 8 hours
  • Nosocomial Pneumonia: 112.5 mg/kg every 6 hours

Dose Calculation for 35 kg Patient:

  • Every 8 hours: 112.5 mg/kg × 35 kg = 3,937.5 mg total dose (3,500 mg piperacillin + 437.5 mg tazobactam)
  • Every 6 hours: Same per-dose amount, but given more frequently

Infusion time: 30 minutes IV infusion 1

Clinical Context from Guidelines

The IDSA skin and soft tissue infection guidelines support piperacillin-tazobactam for mixed infections at 60-75 mg/kg/dose of the piperacillin component every 6 hours 2. However, the FDA label supersedes this with the more recent 112.5 mg/kg dosing for children >9 months.

Important Considerations for Optimal Dosing

Age-Dependent Clearance

At 35 kg, this child is likely >9 months old, placing them in the higher dosing category. Children in this age range have mature renal function and require higher weight-based doses than adults to achieve therapeutic targets 3.

Indication Matters

  • For intra-abdominal infections (appendicitis/peritonitis): Every 8 hours dosing is adequate
  • For nosocomial pneumonia or severe infections: Every 6 hours dosing provides better coverage, especially against Pseudomonas with MIC ≥16 mg/L 4, 5

Extended Infusions for Severe Infections

Recent pharmacokinetic data suggests that for critically ill children or infections with higher MIC organisms, extended infusions may be superior 4, 5:

  • 100 mg/kg every 8 hours infused over 4 hours achieves better target attainment for MICs up to 16 mg/L 6
  • Standard 30-minute infusions may be insufficient for severe infections in children >6 months 4

Practical Dosing Algorithm

  1. Standard infections (uncomplicated intra-abdominal): 112.5 mg/kg every 8 hours over 30 minutes
  2. Severe infections or nosocomial pneumonia: 112.5 mg/kg every 6 hours over 30 minutes
  3. Critically ill or suspected resistant organisms: Consider 100 mg/kg every 6-8 hours as extended infusion over 2-4 hours 4, 5

Safety Monitoring

  • Renal function: Monitor creatinine, especially if used with vancomycin (though additive nephrotoxicity appears minimal in children) 7
  • Adjust for renal impairment: If creatinine clearance <40 mL/min, reduce frequency 1
  • Maximum dose: Do not exceed adult dosing (typically 3.375-4.5 g per dose)

Common Pitfalls

  • Underdosing: Using adult weight-based dosing (50 mg/kg) instead of pediatric dosing (100-112.5 mg/kg) leads to subtherapeutic levels 3
  • Wrong frequency: Using every 8 hours for nosocomial pneumonia when every 6 hours is indicated
  • Ignoring MIC: For organisms with MIC >8 mg/L, standard dosing may fail; consider extended infusions 4, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.